Avicenna Journal of Medicine

REVIEW ARTICLE
Year
: 2016  |  Volume : 6  |  Issue : 3  |  Page : 65--68

Critical congenital heart disease screening


Mohammed A Chamsi-Pasha1, Hassan Chamsi-Pasha2 
1 Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA
2 Division of Cardiovascular Medicine, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia

Correspondence Address:
Mohammed A Chamsi-Pasha
Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska
USA

Critical congenital heart disease (CCHD) is a heart lesion for which neonates require early surgical intervention to survive. Without intervention, the rates of mortality and survival with significant disability are extremely high. Early diagnosis can potentially improve health outcomes in newborns with CCHD. Until recent years, no routine screening protocol existed. In the last few years, pulse oximetry screening for CCHD in newborns has been added to the list of recommended uniform screening panels and advocated by several health-care authorities. A positive screening test result warrants an echocardiogram to evaluate for CCHD. Newborn screens do not usually require parental consent. However, most of the states mandates in the United States include a statement allowing exemption from the screen on the basis of parental religious or personal beliefs.


How to cite this article:
Chamsi-Pasha MA, Chamsi-Pasha H. Critical congenital heart disease screening.Avicenna J Med 2016;6:65-68


How to cite this URL:
Chamsi-Pasha MA, Chamsi-Pasha H. Critical congenital heart disease screening. Avicenna J Med [serial online] 2016 [cited 2019 Oct 22 ];6:65-68
Available from: http://www.avicennajmed.com/article.asp?issn=2231-0770;year=2016;volume=6;issue=3;spage=65;epage=68;aulast=Chamsi-Pasha;type=0